Hannah R. Concannon

Hannah R. Concannon

Auto-generated profile, based on publicly available information

Hannah R. Concannon

Duke University School of Medicine, DUMC 2927, 124 Davison Building, Durham, NC 27710, United States

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in The Journal of Rheumatology
Verified
Journal Article
Closed access
HCHannah R. Concannon
Hannah R. Concannon
KSKai Sun
Kai Sun
JRJennifer L. Rogers
Jennifer L. Rogers
MCMegan E.B. Clowse
Megan E.B. Clowse
RRRachel L. Randell
Rachel L. Randell
RSRebecca E. Sadun
Rebecca E. Sadun
Objective: Medication adherence poses a challenge for young patients with systemic lupus erythematosus (SLE), who experience more active disease and damage than their older counterparts. This study aimed to quantify the rate of medication nonadherence by age and to identify differences in reasons for nonadherence between younger and older patients with SLE. Methods: We collected responses to the Domains of Subjective Extent of Nonadherence (DOSE-Nonadherence)-SLE questionnaire, a clinical tool validated to measure extent of and reasons for medication nonadherence in SLE. Analysis included 336 surveys completed between February 2020 and June 2024. Proportions and odds ratios (ORs) for extent of and reasons for nonadherence were determined across age groups, and logistic regression was used to determine relationships of nonadherence with age and other covariates. Results: Medication nonadherence differed significantly across age groups 18-29, 30-39, 40-49, and 50+ ( P < 0.001). For each increased year of age, self-reported nonadherence decreased by 2% ( P < 0.05). Black race and Hispanic ethnicity were also predictive of nonadherence across age groups. The < 30 age group was more likely to report nonadherence due to inability to fill medications on time (OR 3.72, 95% CI 1.53-9.02) and needing to take medicines with food (OR 2.55, 95% CI 1.06-6.13). Conclusion: Younger patients reported greater extent of nonadherence, often due to logistical impediments. In addition to counseling young adults with SLE on the importance of medications, rheumatologists should, when possible, offer support to help them overcome challenges in obtaining and taking medicines. Approaches to understanding and intervening on medication nonadherence in SLE may need to be tailored by age.


8 June 2026 in Health Care Transitions
Verified
Journal Article
Open access
HCHannah R. Concannon
Hannah R. Concannon
BHBrian Halstater
Brian Halstater
SMSara Mazzarelli
Sara Mazzarelli
NTNatalie L. Tammen
Natalie L. Tammen
AFAnne Fields
Anne Fields
RSRebecca E. Sadun
Rebecca E. Sadun
To determine care outcomes and utilization patterns for rheumatology patients seen in a multidisciplinary Young Adult Rheumatology Clinic (YARC) with embedded primary care, compared to patients directly transferred (DT) from pediatric to adult rheumatology clinics. Data were collected two years prior to and three years after transfer for YARC and similarly aged DT patients. Difference-in-differences were calculated for show rates and acute care utilization before and after transfer. Vaccination and contraception uptake were compared. Trends in anxiety and depressive symptoms were examined for YARC patients using PHQ and GAD screeners. Semi-structured interviews were conducted with a subset of YARC patients to understand perceptions of the clinic’s impact. Twenty-two patients enrolled in the YARC were included in the study, 13 of whom have systemic lupus erythematosus (SLE), alongside 12 directly transferred SLE patients. The show rate for patients seen in the YARC increased by 14%, whereas the DT show rate decreased by 13%. Emergency department visits and hospital admissions increased post-transfer only in the DT group post-transfer. YARC patients were more likely to be up to-date on TDaP and HPV vaccines and to use highly effective contraception. Anxiety and depressive symptoms remained stable post-transfer in YARC patients. Patients also reported appreciating the efficiency benefits of the patient-centered medical home (PCMH) model inherent in the YARC. Compared with traditional transfer to adult rheumatology, the YARC reduced acute care utilization and improved the no-show rate. Additionally, young adult rheumatology patients valued the PCMH model and were more likely to adhere to recommended preventive care practices.